Date: 2014-06-18
Type of information: Clinical research agreement
Compound:
Company: Recipharm (Sweden) Clinical Trial Consultants - CTC (Sweden)
Therapeutic area:
Type agreement: collaboration clinical research
Action mechanism:
Disease:
Details: * On June 18, 2014, CTC Clinical Trial Consultants and Recipharm Pharmaceutical Development announced that they have entered into a collaboration. Together the two companies will offer a complete set of packages for Phase I studies including development and manufacture of clinical trial material. The scope will cover planning, performing and evaluation of the clinical trial. Recipharm is a CDMO (Contract Development and Manufacturing Organisation). The compant offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and pharmaceutical product development. CTC is a specialist CRO focused on the early clinical studies in translational medicine offering our clients in the pharmaceutical, CRO and medical technology sectors cost-effective conduct of hospital-based early clinical trials (phase 0/I/IIa). The company operates a dedicated 12-bed research clinic at the University Hospital in Uppsala, combined with two SMO-sites in Linköping and Uppsala, Sweden.
Financial terms:
Latest news:
